We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IDXX market cap is 42.62B. The company's latest EPS is USD 11.0401 and P/E is 48.01.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 964.1M | 1B | 975.54M | 954.29M | 998.43M |
| Operating Income | 298.96M | 263.8M | 303.89M | 266.19M | 316.53M |
| Net Income | 235.58M | 203.3M | 232.84M | 216.15M | 242.68M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.71B | 3.22B | 3.37B | 3.66B | 3.9B |
| Operating Income | 694.52M | 932.03M | 898.77M | 1.1B | 1.13B |
| Net Income | 581.78M | 744.85M | 679.09M | 845.04M | 887.87M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.35B | 3.41B | 3.35B | 3.29B | 3.21B |
| Total Liabilities | 1.78B | 1.83B | 1.73B | 1.7B | 1.77B |
| Total Equity | 1.57B | 1.58B | 1.62B | 1.6B | 1.45B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.29B | 2.44B | 2.75B | 3.26B | 3.29B |
| Total Liabilities | 1.66B | 1.75B | 2.14B | 1.78B | 1.7B |
| Total Equity | 632.8M | 689.99M | 608.74M | 1.48B | 1.6B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 198.59M | 446.9M | 666.98M | 929M | 237.96M |
| Investing | -106.94M | -139.85M | -167.22M | -207.06M | -29.61M |
| Financing | -144.07M | -354.31M | -645.29M | -878.07M | -330.32M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 648.06M | 755.55M | 542.98M | 906.51M | 929M |
| Investing | -109.38M | -292.97M | -195.35M | -125.25M | -207.06M |
| Financing | -248.42M | -697.41M | -370.94M | -442M | -878.07M |
| Market Cap | 42.62B |
| Price to Earnings Ratio | 48.01 |
| Price to Sales Ratio | 10.94 |
| Price to Cash Ratio | 147.87 |
| Price to Book Ratio | 26.72 |
| Dividend Yield | - |
| Shares Outstanding | 80.42M |
| Average Volume (1 week) | 412.55k |
| Average Volume (1 Month) | 489.32k |
| 52 Week Change | 9.01% |
| 52 Week High | 549.52 |
| 52 Week Low | 356.14 |
| Spread (Intraday) | 0.33 (0.06%) |
| Company Name | IDEXX Laboratories Inc |
| Address |
corporation trust center 1209 wilmington, delaware 19801 |
| Website | https://www.idexx.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
